🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is evaluating the safety and immunogenicity of GSK Biologicals' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-08-01
Trial ID
NCT00129129
This study is designed to test the immunogenicity and reactogenicity of the...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-06-17
Trial ID
NCT01144299
Treatments Being Tested
This study is evaluating the safety and immunogenicity of Hib-MenCY-TT vacc...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-04-11
Trial ID
NCT00134719
Treatments Being Tested
The goal of this observational study is to learn about vaccine immunity in ...
Status
Recruiting
Location
University Hospital Bern
Start Date
2023-11-14
Trial ID
NCT06333275
This study is designed to test the immunogenicity and safety of an investig...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-10-01
Trial ID
NCT01196975
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity and safety of t...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-10-23
Trial ID
NCT01974895
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity and the safety ...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-09-30
Trial ID
NCT01440387
Treatments Being Tested
This study is designed to test the safety and immunogenicity of Fluviral® (...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-07-11
Trial ID
NCT00929331
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, immunogenicity and s...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-10-01
Trial ID
NCT01439360
The purpose of this study is to assess the immunogenicity and safety of GSK...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-10-01
Trial ID
NCT02242643
Treatments Being Tested